{"id":18580,"date":"2017-12-06T17:55:02","date_gmt":"2017-12-06T16:55:02","guid":{"rendered":"http:\/\/localhost:8888\/TG180623\/?p=18580"},"modified":"2021-11-20T11:00:22","modified_gmt":"2021-11-20T10:00:22","slug":"transgene-et-bioinvent-collaborent-sur-un-programme-de-virus-oncolytique-de-nouvelle-generation-exprimant-un-anticorps-anti-ctla-4-pour-traiter-les-tumeurs-solides","status":"publish","type":"post","link":"https:\/\/www.transgene.com\/fr\/transgene-et-bioinvent-collaborent-sur-un-programme-de-virus-oncolytique-de-nouvelle-generation-exprimant-un-anticorps-anti-ctla-4-pour-traiter-les-tumeurs-solides\/","title":{"rendered":"Transgene et BioInvent collaborent sur un programme de virus oncolytique de nouvelle g\u00e9n\u00e9ration exprimant un anticorps anti-CTLA-4 pour traiter les tumeurs solides"},"content":{"rendered":"<p><a href=\"..\/wp-content\/uploads\/2017\/12\/CP-BioInventTransgene-FR-6-Dec.pdf\">Transgene et BioInvent collaborent sur un programme de virus oncolytique de nouvelle g\u00e9n\u00e9ration exprimant un anticorps anti-CTLA-4 pour traiter les tumeurs solides<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Transgene et BioInvent collaborent sur un programme de virus oncolytique de nouvelle g\u00e9n\u00e9ration exprimant un anticorps anti-CTLA-4 pour traiter les tumeurs solides<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","_uag_custom_page_level_css":"","footnotes":""},"categories":[130,11,56],"tags":[],"class_list":["post-18580","post","type-post","status-publish","format-standard","hentry","category-130","category-press-release-fr","category-invirio-fr","entry"],"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"post-thumbnail":false},"uagb_author_info":{"display_name":"alcyon","author_link":"https:\/\/www.transgene.com\/fr\/author\/alcyon\/"},"uagb_comment_info":0,"uagb_excerpt":"Transgene et BioInvent collaborent sur un programme de virus oncolytique de nouvelle g\u00e9n\u00e9ration exprimant un anticorps anti-CTLA-4 pour traiter les tumeurs solides","_links":{"self":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/18580","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/comments?post=18580"}],"version-history":[{"count":0,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/18580\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/media?parent=18580"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/categories?post=18580"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/tags?post=18580"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}